Wound Debridement Market size was valued at USD 6.54 billion in 2023 and is likely to cross USD 14.47 billion by the end of 2036, expanding at more than 6.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of wound debridement is estimated at USD 6.87 billion.
. Increasing incidence of wounds due to diabetes, venous leg ulcers and surgeries are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and increasing wound infections. According to the research, the annual incidence of diabetic foot ulcer worldwide is between 9.1 to 26.1 million.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
6.3% |
|
Base Year Market Size (2023) |
USD 6.54 billion |
|
Forecast Year Market Size (2036) |
USD 14.47 billion |
|
Regional Scope |
|
The market is segmented based on product into gel and ointment, medical debridement pads, medical gauzes, enzymatic debridement products and, others, out of which, the gels segment is anticipated to grab the largest share by the end of 2021 as gels are having property to avoid enzymatic activity and drug interaction with food and drinks. In addition, no inflammation, less bleeding, removal of necrotic tissue safely and without infection are some factors that are contributing to the growth of this segment.
On the basis of application, diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. Furthermore, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
By Therapy Type |
|
|
By Wound Type |
|
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is likely to hold largest revenue share by 2036, due to booming economies, and reforms to improve healthcare infrastructure facilities in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, the growth of the region can be attributed to the presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services. As per the analysis of American Diabetes Association, diabetes affects 30 million people in the US and more than 415 million people worldwide.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?